OXLD1
gene geneOn this page
Also known as MGC104712
Summary
OXLD1 (oxidoreductase like domain containing 1, HGNC:27901) is a protein-coding gene on chromosome 17q25.3, encoding Oxidoreductase-like domain-containing protein 1 (Q5BKU9).
Located in mitochondrion.
Source: NCBI Gene 339229 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 19 total — 1 pathogenic
- MANE Select transcript:
NM_001039842
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27901 |
| Approved symbol | OXLD1 |
| Name | oxidoreductase like domain containing 1 |
| Location | 17q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC104712 |
| Ensembl gene | ENSG00000204237 |
| Ensembl biotype | protein_coding |
| Entrez | 339229 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 3 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000374741, ENST00000571092, ENST00000571503, ENST00000571757, ENST00000573786, ENST00000575963, ENST00000575992, ENST00000934282
RefSeq mRNA: 4 — MANE Select: NM_001039842
NM_001039842, NM_001304994, NM_001304995, NM_001304999
CCDS: CCDS32766, CCDS77132
Canonical transcript exons
ENST00000374741 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001464500 | 81665036 | 81665584 |
| ENSE00001506236 | 81666518 | 81666605 |
Expression profiles
Bgee: expression breadth ubiquitous, 265 present calls, max score 91.48.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.5173 / max 87.8434, expressed in 1804 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 168777 | 14.9347 | 1804 |
| 168778 | 0.5826 | 230 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 91.48 | gold quality |
| right testis | UBERON:0004534 | 90.79 | gold quality |
| apex of heart | UBERON:0002098 | 90.76 | gold quality |
| right adrenal gland | UBERON:0001233 | 90.66 | gold quality |
| left testis | UBERON:0004533 | 90.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 90.46 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 90.13 | gold quality |
| left adrenal gland | UBERON:0001234 | 89.88 | gold quality |
| granulocyte | CL:0000094 | 89.72 | gold quality |
| body of stomach | UBERON:0001161 | 89.65 | gold quality |
| spleen | UBERON:0002106 | 89.41 | gold quality |
| pancreatic ductal cell | CL:0002079 | 89.19 | gold quality |
| adrenal cortex | UBERON:0001235 | 89.15 | gold quality |
| skin of abdomen | UBERON:0001416 | 88.98 | gold quality |
| skin of leg | UBERON:0001511 | 88.94 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.87 | gold quality |
| right uterine tube | UBERON:0001302 | 88.73 | gold quality |
| monocyte | CL:0000576 | 88.44 | gold quality |
| testis | UBERON:0000473 | 88.35 | gold quality |
| mononuclear cell | CL:0000842 | 88.24 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 88.17 | gold quality |
| leukocyte | CL:0000738 | 88.11 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.04 | gold quality |
| right lobe of liver | UBERON:0001114 | 87.97 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.93 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 87.91 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.91 | gold quality |
| gingival epithelium | UBERON:0001949 | 87.82 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 87.80 | gold quality |
| lower esophagus | UBERON:0013473 | 87.76 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.32 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting OXLD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-6776-3P | 98.38 | 66.34 | 655 |
| HSA-MIR-4294 | 97.86 | 65.72 | 1110 |
| HSA-MIR-125A-3P | 97.04 | 66.92 | 902 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Oxld1 | ENSMUSG00000039670 |
| rattus_norvegicus | Oxld1 | ENSRNOG00000047517 |
| drosophila_melanogaster | CG5500 | FBGN0039461 |
| caenorhabditis_elegans | WBGENE00016764 |
Protein
Protein identifiers
Oxidoreductase-like domain-containing protein 1 — Q5BKU9 (reviewed: Q5BKU9)
All UniProt accessions (3): Q5BKU9, I3L208, I3L247
RefSeq proteins (4): NP_001034931, NP_001291923, NP_001291924, NP_001291928 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019180 | Oxidoreductase-like_N | Domain |
| IPR039251 | OXLD1 | Family |
Pfam: PF09791
UniProt features (5 total): chain 1, domain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5BKU9-F1 | 65.31 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN, GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, MULLIGHAN_MLL_SIGNATURE_1_UP, WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP, MARTENS_TRETINOIN_RESPONSE_DN, LU_EZH2_TARGETS_UP, LEE_BMP2_TARGETS_UP, BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING, PECE_MAMMARY_STEM_CELL_UP, LIM_MAMMARY_STEM_CELL_DN, RB_P130_DN.V1_UP, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
478 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OXLD1 | ANTKMT | Q9BQD7 | 505 |
| OXLD1 | OGFOD3 | Q6PK18 | 504 |
| OXLD1 | TMEM242 | Q9NWH2 | 497 |
| OXLD1 | PIGBOS1 | A0A0B4J2F0 | 474 |
| OXLD1 | LYRM9 | A8MSI8 | 464 |
| OXLD1 | DHRS4L2 | Q6PKH6 | 453 |
| OXLD1 | SMIM26 | A0A096LP01 | 451 |
| OXLD1 | REX1BD | Q96EN9 | 441 |
| OXLD1 | C5orf63 | A6NC05 | 434 |
| OXLD1 | MIGA2 | Q7L4E1 | 409 |
| OXLD1 | DHRS4 | Q9BTZ2 | 334 |
| OXLD1 | SLC35A4 | Q96G79 | 331 |
| OXLD1 | ACOT13 | Q9NPJ3 | 329 |
| OXLD1 | WDR45B | Q5MNZ6 | 323 |
| OXLD1 | SNRPB2 | P08579 | 311 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM38A | DOK2 | psi-mi:“MI:0914”(association) | 0.530 |
| LINC03122 | H2AX | psi-mi:“MI:0914”(association) | 0.530 |
| C1orf220 | HCCS | psi-mi:“MI:0914”(association) | 0.530 |
| LCN15 | POTEF | psi-mi:“MI:0914”(association) | 0.530 |
| HSPB9 | USP12 | psi-mi:“MI:0914”(association) | 0.530 |
| OXLD1 | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| HVCN1 | DOK2 | psi-mi:“MI:0914”(association) | 0.350 |
| CENPM | DOK2 | psi-mi:“MI:0914”(association) | 0.350 |
| RNASE13 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| OXLD1 | PRORP | psi-mi:“MI:0914”(association) | 0.350 |
| SLC7A1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (114): OXLD1 (Affinity Capture-MS), CARS2 (Affinity Capture-MS), MUT (Affinity Capture-MS), MTIF2 (Affinity Capture-MS), KIAA0391 (Affinity Capture-MS), AARS2 (Affinity Capture-MS), HSD17B8 (Affinity Capture-MS), MOCS1 (Affinity Capture-MS), TOP3A (Affinity Capture-MS), PUS1 (Affinity Capture-MS), CLPX (Affinity Capture-MS), ALAS1 (Affinity Capture-MS), AUH (Affinity Capture-MS), CETN3 (Affinity Capture-MS), GLDC (Affinity Capture-MS)
ESM2 similar proteins: A7YVI8, F1QCY8, F5HB62, F5HF68, O75381, O95343, P03177, P0C8B5, P36552, P53814, P97287, Q02873, Q07820, Q0IH40, Q1HVD1, Q29RJ0, Q3B7D0, Q3KSQ2, Q3UHD9, Q4VC12, Q5BIR3, Q5BKU9, Q5E9N0, Q5R4R7, Q5R7Q6, Q5XIX0, Q62233, Q642G4, Q6BCB4, Q6DGF9, Q6Y2X3, Q7L2J0, Q7YRZ9, Q80TL4, Q89420, Q8CGU4, Q8CI12, Q8HYS5, Q8K3A9, Q921R4
Diamond homologs: A7YVI8, Q5BKU9, Q5R7Q6, Q9CR10, Q9USH2, Q02873, B1AS42
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2445210 | Single allele | Pathogenic |
SpliceAI
452 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:81666157:A:AC | donor_gain | 1.0000 |
| 17:81666286:T:TA | donor_gain | 1.0000 |
| 17:81666149:CTTCA:C | donor_gain | 0.9900 |
| 17:81666162:A:C | donor_gain | 0.9900 |
| 17:81666165:AGT:A | donor_gain | 0.9900 |
| 17:81666167:T:TA | donor_gain | 0.9900 |
| 17:81666249:A:AC | donor_gain | 0.9900 |
| 17:81666368:T:TA | donor_gain | 0.9900 |
| 17:81666505:T:TA | donor_gain | 0.9900 |
| 17:81665581:CCCC:C | acceptor_gain | 0.9800 |
| 17:81665582:CCCC:C | acceptor_gain | 0.9800 |
| 17:81666148:A:AC | donor_gain | 0.9800 |
| 17:81666149:C:CC | donor_gain | 0.9800 |
| 17:81666151:T:TA | donor_gain | 0.9800 |
| 17:81666153:A:AC | donor_gain | 0.9800 |
| 17:81666154:C:CC | donor_gain | 0.9800 |
| 17:81666439:T:TA | donor_gain | 0.9800 |
| 17:81665582:CCC:C | acceptor_gain | 0.9700 |
| 17:81665583:CCC:C | acceptor_gain | 0.9700 |
| 17:81666158:T:C | donor_gain | 0.9700 |
| 17:81666276:CCGGG:C | donor_gain | 0.9700 |
| 17:81666440:C:A | donor_gain | 0.9700 |
| 17:81666481:G:A | donor_gain | 0.9700 |
| 17:81665583:CC:C | acceptor_gain | 0.9600 |
| 17:81665584:CC:C | acceptor_gain | 0.9600 |
| 17:81666291:T:A | donor_gain | 0.9600 |
| 17:81665583:CCCT:C | acceptor_loss | 0.9500 |
| 17:81665586:T:G | acceptor_loss | 0.9500 |
| 17:81666145:CCAA:C | donor_gain | 0.9400 |
| 17:81666251:TGAGA:T | donor_gain | 0.9400 |
AlphaMissense
946 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:81665345:C:A | W100C | 0.993 |
| 17:81665345:C:G | W100C | 0.993 |
| 17:81665243:G:C | F134L | 0.989 |
| 17:81665243:G:T | F134L | 0.989 |
| 17:81665245:A:G | F134L | 0.989 |
| 17:81665249:C:A | K132N | 0.983 |
| 17:81665249:C:G | K132N | 0.983 |
| 17:81665347:A:G | W100R | 0.983 |
| 17:81665347:A:T | W100R | 0.983 |
| 17:81665229:A:G | I139T | 0.980 |
| 17:81665244:A:G | F134S | 0.980 |
| 17:81665244:A:C | F134C | 0.975 |
| 17:81665337:T:C | Y103C | 0.974 |
| 17:81665337:T:G | Y103S | 0.974 |
| 17:81665352:C:G | C98S | 0.972 |
| 17:81665352:C:T | C98Y | 0.972 |
| 17:81665353:A:T | C98S | 0.972 |
| 17:81665362:A:G | C95R | 0.972 |
| 17:81665353:A:G | C98R | 0.970 |
| 17:81665376:C:G | C90S | 0.969 |
| 17:81665377:A:T | C90S | 0.969 |
| 17:81665241:A:T | L135H | 0.965 |
| 17:81665377:A:G | C90R | 0.965 |
| 17:81665352:C:A | C98F | 0.962 |
| 17:81665373:C:G | C91S | 0.962 |
| 17:81665374:A:T | C91S | 0.962 |
| 17:81665338:A:C | Y103D | 0.961 |
| 17:81665361:C:G | C95S | 0.961 |
| 17:81665362:A:T | C95S | 0.961 |
| 17:81665375:G:C | C90W | 0.961 |
dbSNP variants (sampled 300 via entrez): RS1000030742 (17:81667578 C>A,T), RS1001800344 (17:81666015 C>T), RS1003013854 (17:81666803 G>C,T), RS1003191696 (17:81666400 G>A,T), RS1003265369 (17:81666098 CG>C), RS1004047628 (17:81666161 A>C), RS1004979889 (17:81667162 C>T), RS1006210744 (17:81665690 A>C,G), RS1008100101 (17:81666650 A>C,G), RS1008488738 (17:81668407 C>T), RS1009240512 (17:81667267 C>T), RS1009770309 (17:81666663 C>T), RS1009827502 (17:81666791 G>A,C,T), RS1010108914 (17:81665373 C>G), RS1010573363 (17:81665616 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_133 | Refractive error | 2.000000e-50 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| bufotalin | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cyclosporine | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TB80 | HAP1 OXLD1 (-) 1 | Cancer cell line | Male |
| CVCL_TB81 | HAP1 OXLD1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.